Protection against topical damaging agents and stimulation of gastric nonparietal cell secretion by 16, 16-dimethyl PGE2.
D015064:16,16-Dimethylprostaglandin E2 / Q000494:pharmacology*; D000818:Animals; D002463:Cell Membrane Permeability / Q000187:drug effects; D005750:Gastric Juice / Q000378:metabolism; D005753:Gastric Mucosa / Q000187:drug effects* / Q000378:metabolism; D007213:Indomethacin / Q000037:antagonists & inhibitors*; D011459:Prostaglandins E, Synthetic / Q000494:pharmacology*; D011522:Protons; D051381:Rats; D012964:Sodium / Q000378:metabolism
D011459:Prostaglandins E, Synthetic; D011522:Protons; D012964:Sodium; D015064:16,16-Dimethylprostaglandin E2; D007213:Indomethacin